Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
16,385,263
-
Total 13F shares
-
3,414,591
-
Share change
-
-1,485,419
-
Total reported value
-
$10,755,535
-
Price per share
-
$3.15
-
Number of holders
-
49
-
Value change
-
-$7,918,322
-
Number of buys
-
22
-
Number of sells
-
38
Institutional Holders of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) as of Q2 2023
As of 30 Jun 2023,
Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,414,591 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, Nantahala Capital Management, LLC, Bank of New York Mellon Corp, GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, PERRITT CAPITAL MANAGEMENT INC, D. E. Shaw & Co., Inc., and Cahill Wealth Management, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.